Company profile for Exyte

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Exyte is a global leader in design, engineering services and delivery of facilities for high-tech industries With a history of more than 100 years, the company has developed a unique expertise in controlled and regulated environments. Exyte has a truly global footprint, serving the most technically demanding clients in markets such as semiconductors, batteries, pharmaceuticals, biotechnology, and data centers. The company off...
Exyte is a global leader in design, engineering services and delivery of facilities for high-tech industries With a history of more than 100 years, the company has developed a unique expertise in controlled and regulated environments. Exyte has a truly global footprint, serving the most technically demanding clients in markets such as semiconductors, batteries, pharmaceuticals, biotechnology, and data centers. The company offers a full range of services from consulting to the managing of turnkey solutions – delivered to the highest quality and safety standards.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Loewentorbogen 9b 70376 Stuttgart
Telephone
Telephone
+49 711 8804-0
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/exyte-completes-pharmaplan-integration-a-to-z-execution-in-gmp-facilities-302620727.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/exyte-acquires-ttp-group-to-accelerate-growth-of-biopharma-and-life-sciences-business-302238985.html

PR NEWSWIRE
05 Sep 2024

https://www.prnewswire.com/news-releases/fiscal-year-2023-exyte-experiences-strong-growth-in-europe-and-the-usa-302111518.html

PR NEWSWIRE
09 Apr 2024

https://www.prnewswire.com/news-releases/profitable-growth-continues-exyte-with-remarkable-6m2022-results-and-uplifted-year-end-outlook-301606349.html

PRNEWSWIRE
16 Aug 2022
Wacker Chemie invests 100 million euros in mRNA factory
Wacker Chemie invests 100 million euros in mRNA factory

05 Jul 2022

// Zuzanna Szymanska REUTERS

https://www.reuters.com/business/healthcare-pharmaceuticals/wacker-chemie-invests-100-million-euros-mrna-factory-2022-07-05/

Zuzanna Szymanska REUTERS
05 Jul 2022

https://www.prnewswire.com/news-releases/exyte-closes-2021-with-record-order-intake-301469637.html

PRNEWSWIRE
27 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty